A novel human ghrelin variant (in1-ghrelin) and ghrelin-O-acyltransferase are overexpressed in breast cancer: Potential pathophysiological relevance

PLoS ONE

Volumn 6, Issue 8, 2011, Pages

  Gahete, Manuel D ^a   Córdoba Chacón, José ^a   Hergueta Redondo, Marta ^b   Martínez Fuentes, Antonio J ^a   Kineman, Rhonda D ^c   Moreno Bueno, Gema ^b   Luque, Raúl M ^a   Castaño, Justo P ^a  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b MD ANDERSON CANCER CENTER   (Spain)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; CYCLIN D3; GHRELIN; GHRELIN O ACYLTRANSFERASE; GHRELIN RECEPTOR; GHRELIN RECEPTOR 1A; GHRELIN RECEPTOR 1B; IN1 GHRELIN; MESSENGER RNA; UNCLASSIFIED DRUG; DNA; GHRELIN O ACYLTRANSFERASE, HUMAN; GHRELIN O-ACYLTRANSFERASE, HUMAN; PRIMER DNA;

ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CELL CULTURE; CARBOXY TERMINAL SEQUENCE; CELL PROLIFERATION; CELL STRAIN MDA MB 231; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME SUBSTRATE COMPLEX; EXON; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRON; NUCLEOTIDE SEQUENCE; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN VARIANT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; AMINO ACID SEQUENCE; ANIMAL; BABOON; BREAST TUMOR; ENZYMOLOGY; FEMALE; GENETICS; METABOLISM; MOLECULAR GENETICS; TUMOR CELL LINE; WESTERN BLOTTING;

CAPRA HIRCUS;

ACYLTRANSFERASES; AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA; DNA PRIMERS; FEMALE; GHRELIN; HUMANS; MOLECULAR SEQUENCE DATA; PAPIO; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79961174491     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0023302     Document Type: Article

References (48)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, et al. (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402 (6762): 656-60.
2. Lago F, Gonzalez-Juanatey JR, Casanueva FF, Gomez-Reino J, Dieguez C, et al. (2005) Ghrelin, the same peptide for different functions: player or bystander? Vitam Horm 71: 405-32.
3. Gutierrez JA, Solenberg PJ, Perkins DR, Willency JA, Knierman MD, et al. (2008) Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci U S A 105 (17): 6320-5.
4. Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL, (2008) Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 132 (3): 387-96.
5. Horvath TL, Diano S, Sotonyi P, Heiman M, Tschop M, (2001) Minireview: ghrelin and the regulation of energy balance-a hypothalamic perspective. Endocrinology 142 (10): 4163-9.
6. van der Lely AJ, Tschop M, Heiman ML, Ghigo E, (2004) Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 25 (3): 426-57.
7. Jeffery PL, Murray RE, Yeh AH, McNamara JF, Duncan RP, et al. (2005) Expression and function of the ghrelin axis, including a novel preproghrelin isoform, in human breast cancer tissues and cell lines. Endocr Relat Cancer 12 (4): 839-50.
8. Lanfranco F, Baldi M, Cassoni P, Bosco M, Ghe C, et al. (2008) Ghrelin and prostate cancer. Vitam Horm 77: 301-24.
9. Leontiou CA, Franchi G, Korbonits M, (2007) Ghrelin in neuroendocrine organs and tumours. Pituitary 10 (3): 213-25.
10. Nikolopoulos D, Theocharis S, Kouraklis G, (2009) Ghrelin's role on gastrointestinal tract cancer. Surg Oncol 19 (1): e2-e10.
11. Barzon L, Pacenti M, Masi G, Stefani AL, Fincati K, et al. (2005) Loss of growth hormone secretagogue receptor 1a and overexpression of type 1b receptor transcripts in human adrenocortical tumors. Oncology 68 (4-6): 414-21.
12. Carraro G, Albertin G, Abudukerimu A, Aragona F, Nussdorfer GG, (2004) Growth hormone secretagogue receptor subtypes 1a and 1b are expressed in the human adrenal cortex. Int J Mol Med 13 (2): 295-8.
13. Takahashi K, Furukawa C, Takano A, Ishikawa N, Kato T, et al. (2006) The neuromedin U-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer. Cancer Res 66 (19): 9408-19.
14. Zhu X, Cao Y, Voogd K, Steiner DF, (2006) On the processing of proghrelin to ghrelin. J Biol Chem 281 (50): 38867-70.
15. Takahashi T, Ida T, Sato T, Nakashima Y, Nakamura Y, et al. (2009) Production of n-octanoyl-modified ghrelin in cultured cells requires prohormone processing protease and ghrelin O-acyltransferase, as well as n-octanoic acid. J Biochem 146 (5): 675-82.
16. Garg A, (2007) The ongoing saga of obestatin: is it a hormone? J Clin Endocrinol Metab 92 (9): 3396-8.
17. Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch R, et al. (2005) Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310 (5750): 996-9.
18. Karaoglu A, Aydin S, Dagli AF, Cummings DE, Ozercan IH, et al. (2009) Expression of obestatin and ghrelin in papillary thyroid carcinoma. Mol Cell Biochem 323 (1-2): 113-8.
19. Tsolakis AV, Grimelius L, Stridsberg M, Falkmer SE, Waldum HL, et al. (2009) Obestatin/ghrelin cells in normal mucosa and endocrine tumours of the stomach. Eur J Endocrinol 160 (6): 941-9.
20. Volante M, Rosas R, Ceppi P, Rapa I, Cassoni P, et al. (2009) Obestatin in human neuroendocrine tissues and tumours: expression and effect on tumour growth. J Pathol 218 (4): 458-66.
21. Seim I, Collet C, Herington AC, Chopin LK, (2007) Revised genomic structure of the human ghrelin gene and identification of novel exons, alternative splice variants and natural antisense transcripts. BMC Genomics 8: 298.
22. Seim I, Herington AC, Chopin LK, (2009) New insights into the molecular complexity of the ghrelin gene locus. Cytokine Growth Factor Rev 20 (4): 297-304.
23. Hosoda H, Kojima M, Matsuo H, Kangawa K, (2000) Purification and characterization of rat des-Gln14-Ghrelin, a second endogenous ligand for the growth hormone secretagogue receptor. J Biol Chem 275 (29): 21995-2000.
24. Yeh AH, Jeffery PL, Duncan RP, Herington AC, Chopin LK, (2005) Ghrelin and a novel preproghrelin isoform are highly expressed in prostate cancer and ghrelin activates mitogen-activated protein kinase in prostate cancer. Clin Cancer Res 11 (23): 8295-303.
25. Jeffery PL, Duncan RP, Yeh AH, Jaskolski RA, Hammond DS, et al. (2005) Expression of the ghrelin axis in the mouse: an exon 4-deleted mouse proghrelin variant encodes a novel C terminal peptide. Endocrinology 146 (1): 432-40.
26. Kineman RD, Gahete MD, Luque RM, (2007) Identification of a mouse ghrelin gene transcript that contains intron 2 and is regulated in the pituitary and hypothalamus in response to metabolic stress. J Mol Endocrinol 38 (5): 511-21.
27. Gahete MD, Cordoba-Chacon J, Salvatori R, Castano JP, Kineman RD, et al. (2010) Metabolic regulation of ghrelin O-acyl transferase (GOAT) expression in the mouse hypothalamus, pituitary, and stomach. Mol Cell Endocrinol 317 (1-2): 154-60.
28. Seim I, Carter SL, Herington AC, Chopin LK, (2009) The proximal first exon architecture of the murine ghrelin gene is highly similar to its human orthologue. BMC Res Notes 2 (1): 85.
29. Sakabe NJ, de Souza SJ, (2007) Sequence features responsible for intron retention in human. BMC Genomics 8: 59.
30. Sarrio D, Palacios J, Hergueta-Redondo M, Gomez-Lopez G, Cano A, et al. (2009) Functional characterization of E- and P-cadherin in invasive breast cancer cells. BMC Cancer 9: 74.
31. Duran-Prado M, Gahete MD, Martinez-Fuentes AJ, Luque RM, Quintero A, et al. (2009) Identification and characterization of two novel truncated but functional isoforms of the somatostatin receptor subtype 5 differentially present in pituitary tumors. J Clin Endocrinol Metab 94 (7): 2634-43.
32. Martinez-Fuentes AJ, Moreno-Fernandez J, Vazquez-Martinez R, Duran-Prado M, de la Riva A, et al. (2006) Ghrelin is produced by and directly activates corticotrope cells from adrenocorticotropin-secreting adenomas. J Clin Endocrinol Metab 91 (6): 2225-31.
33. Taboada GF, Luque RM, Bastos W, Guimaraes RF, Marcondes JB, et al. (2007) Quantitative analysis of somatostatin receptor subtype (SSTR1-5) gene expression levels in somatotropinomas and non-functioning pituitary adenomas. Eur J Endocrinol 156 (1): 65-74.
34. Cordoba-Chacon J, Gahete MD, Duran-Prado M, Pozo-Salas AI, Malagon MM, et al. (2010) Identification and characterization of new functional truncated variants of somatostatin receptor subtype 5 in rodents. Cell Mol Life Sci 67 (7): 1147-63.
35. Gahete MD, Rubio A, Cordoba-Chacon J, Gracia-Navarro F, Kineman RD, et al. (2010) Expression of the ghrelin and neurotensin systems is altered in the temporal lobe of Alzheimer's disease patients. J Alzheimers Dis 22 (3): 819-28.
36. Soares JB, Leite-Moreira AF, (2008) Ghrelin, des-acyl ghrelin and obestatin: three pieces of the same puzzle. Peptides 29 (7): 1255-70.
37. Seim I, Amorim L, Walpole C, Carter S, Chopin LK, et al. (2009) Ghrelin gene-related peptides: multi-functional endocrine/autocrine modulators in health and disease. Clin Exp Pharmacol Physiol 37 (1): 125-31.
38. Matlin AJ, Clark F, Smith CW, (2005) Understanding alternative splicing: towards a cellular code. Nat Rev Mol Cell Biol 6 (5): 386-98.
39. Galante PA, Sakabe NJ, Kirschbaum-Slager N, de Souza SJ, (2004) Detection and evaluation of intron retention events in the human transcriptome. Rna 10 (5): 757-65.
40. Ledee DR, Chen J, Tonelli LH, Takase H, Gery I, et al. (2004) Differential expression of splice variants of chemokine CCL27 mRNA in lens, cornea, and retina of the normal mouse eye. Mol Vis 10: 663-7.
41. Dias Neto E, Correa RG, Verjovski-Almeida S, Briones MR, Nagai MA, et al. (2000) Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. Proc Natl Acad Sci U S A 97 (7): 3491-6.
42. Leung PK, Chow KB, Lau PN, Chu KM, Chan CB, et al. (2007) The truncated ghrelin receptor polypeptide (GHS-R1b) acts as a dominant-negative mutant of the ghrelin receptor. Cell Signal 19 (5): 1011-22.
43. Boyan BD, Sylvia VL, Frambach T, Lohmann CH, Dietl J, et al. (2003) Estrogen-dependent rapid activation of protein kinase C in estrogen receptor-positive MCF-7 breast cancer cells and estrogen receptor-negative HCC38 cells is membrane-mediated and inhibited by tamoxifen. Endocrinology 144 (5): 1812-24.
44. Eisen SF, Brown HA, (2002) Selective estrogen receptor (ER) modulators differentially regulate phospholipase D catalytic activity in ER-negative breast cancer cells. Mol Pharmacol 62 (4): 911-20.
45. Wong SC, Chan JK, Lee KC, Hsiao WL, (2001) Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast. J Pathol 194 (1): 35-42.
46. Cassoni P, Papotti M, Ghe C, Catapano F, Sapino A, et al. (2001) Identification, characterization, and biological activity of specific receptors for natural (ghrelin) and synthetic growth hormone secretagogues and analogs in human breast carcinomas and cell lines. J Clin Endocrinol Metab 86 (4): 1738-45.
47. Jeffery PL, Herington AC, Chopin LK, (2002) Expression and action of the growth hormone releasing peptide ghrelin and its receptor in prostate cancer cell lines. J Endocrinol 172 (3): R7-11.
48. Jeffery PL, Herington AC, Chopin LK, (2003) The potential autocrine/paracrine roles of ghrelin and its receptor in hormone-dependent cancer. Cytokine Growth Factor Rev 14 (2): 113-22.